Left ventricular hypertrophy and myocardial ischaemia in hypertension: the THAMES Study

J E Otterstad1, M Davies, S G Ball

  • 1Medical Department, Vestfold Central Hospital, Toensberg, Norway.

European Heart Journal
|December 1, 1993
PubMed

Insights

A study found that 68% of asymptomatic hypertensive men had left ventricular hypertrophy (LVH). Many with LVH also showed signs of myocardial ischemia, highlighting significant cardiovascular risk in this population.

Area of Science:

  • Cardiology
  • Epidemiology
  • Hypertension Research

Background:

  • Hypertension is a major risk factor for cardiovascular disease.
  • Left ventricular hypertrophy (LVH) is a common adaptation to chronic hypertension.
  • The prevalence of myocardial ischemia in asymptomatic hypertensive patients with LVH is not well-defined.

Purpose of the Study:

  • To determine the prevalence of left ventricular hypertrophy (LVH) in asymptomatic male hypertensive patients.
  • To assess the prevalence of myocardial ischemia in hypertensive patients with LVH.
  • To evaluate the diagnostic utility of exercise ECG and thallium-201 scintigraphy in detecting ischemia.

Main Methods:

  • Multicentre epidemiological study involving 188 asymptomatic male hypertensives.
  • Echocardiography used to diagnose LVH (LV mass index > or = 130 g.m-2).
  • Maximal bicycle ergometer exercise test and exercise thallium-201 scintigraphy performed on patients with LVH.

Main Results:

  • LVH was detected in 127 (68%) of the participants.
  • Significant ST depression on exercise ECG, suggestive of ischemia, was found in 29 men (23%) with LVH.
  • Exercise thallium-201 scintigraphy revealed reversible perfusion defects in 15 of these subjects (52% of those tested).

Conclusions:

  • A high prevalence of LVH exists in hypertensive men selected based on age and blood pressure.
  • A substantial proportion of hypertensive men with LVH exhibit signs of stress-induced myocardial ischemia.
  • These findings underscore the importance of screening for LVH and ischemia in hypertensive patients.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...